Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02493036 · ClinicalTrials.gov registry record · Phase 2
A Single-Dose, Open-Label, Study to Evaluate the Sustainability of the Effects of SYN-010 in Patients With IBS-C
A Phase 2 study, sponsored by Theriva Biologics.
- Completed
- Registry status
- Phase 2
- Development phase
- 54
- Enrollment target
NCT02493036 is a Phase 2 study that has completed, run by Theriva Biologics. The registered enrollment target is 54 participants.
The verdict
NCT02493036, a Phase 2 study, has completed, sponsored by Theriva Biologics.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 54 participants
- Enrollment target
Study Summary
A Single-Dose, Open-Label, Extension Study to Evaluate the Sustainability of the Effects of SYN-010 in Patients with Irritable Bowel Syndrome with Constipation
Interventions
- DRUG SYN-010
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2015-10 |
| Est. Completion | 2015-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02493036
The ClinicalTrials.gov registry entry for NCT02493036 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 54 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Theriva Biologics, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which SYN-010 is the first listed.
NCT02493036 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02493036 about?
NCT02493036 is a clinical study titled "A Single-Dose, Open-Label, Study to Evaluate the Sustainability of the Effects of SYN-010 in Patients With IBS-C". A Single-Dose, Open-Label, Extension Study to Evaluate the Sustainability of the Effects of SYN-010 in Patients with Irritable Bowel Syndrome with Constipation
What is the current status of trial NCT02493036?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 54 participants. The study started on 2015-10. Estimated completion is 2015-12.
What interventions are being tested in trial NCT02493036?
The interventions under investigation include: SYN-010 (DRUG).
Who is sponsoring clinical trial NCT02493036?
This trial is sponsored by Theriva Biologics, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.